Percutaneous aortic valve replacement will become a common treatment for aortic valve disease.
Percutaneous valve replacement is developing into an effective and reproducible therapy for aortic valve stenosis. Initial experience suggests that outcomes compare favorably with conventional valve surgery in selected patients with comorbidities, such as advanced age. Caution is prudent, however, in the future a more mature procedure might represent a viable alternative for a much broader range of patients.
Webb
John G
JG
Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, Canada. webb@providencehealth.bc.ca
D001024:Aortic Valve Stenosis / Q000401:mortality / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D006328:Cardiac Catheterization / Q000009:adverse effects / Q000295:instrumentation; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D018579:Patient Selection; D011474:Prosthesis Design; D020127:Recovery of Function; D018570:Risk Assessment; D013997:Time Factors; D016896:Treatment Outcome